`
`Luke L. Dauchot (SBN 229829)
` luke.dauchot@kirkland.com
`Alexander F. MacKinnon (SBN 146883)
` alexander.mackinnon@kirkland.com
`Nimalka R. Wickramasekera (SBN 268518)
` nimalka.wickramasekera@kirkland.com
`Kirkland & Ellis LLP
`333 South Hope Street
`Los Angeles, California 90071
`Telephone: (213) 680-8400
`Facsimile: (213) 680-8500
`
`Attorneys for Plaintiffs/Counterclaim
`Defendants
`
`
`
`Todd G. Miller (SBN 163200)
`miller@fr.com
`Michael A. Amon (SBN 226221)
`amon@fr.com
`Fish & Richardson P.C.
`12390 El Camino Real
`San Diego, California 92130
`Phone: 858-678-5070/Fax: 858-678-5099
`
`Frank E. Scherkenbach (SBN 142549)
`scherkenbach@fr.com
`Fish & Richardson P.C.
`One Marina Park Drive
`Boston, Massachusetts 02210-1878
`Phone: 617-542-5070/Fax: 617-542-8906
`
`Keeley I. Vega (SBN 259928)
`kvega@fr.com
`Neil A. Warren (SBN 272770)
`warren@fr.com
`Fish & Richardson P.C.
`500 Arguello St., Ste. 500
`Redwood City, California 94063
`Telephone: 650-839-5070/Fax: 650-839-5071
`
`Attorneys for Defendant/Counterclaimant
`
`UNITED STATES DISTRICT COURT
`
`SOUTHERN DISTRICT OF CALIFORNIA
`
`CASE NO. 3:12-cv-02738-CAB (MDD)
`
`JOINT DISCOVERY PLAN
`PURSUANT TO FED. R. CIV. P. 26(f)
`
`
`
`Date: February 21, 2013
`Time: 9:30 a.m.
`Location: Hon. Dembin’s Chambers
`Judge: Hon. Mitchell D. Dembin
`
`)))))))))))))
`
`))
`
`WARSAW ORTHOPEDIC, INC.; MEDTRONIC
`SOFAMOR DANEK U.S.A., INC.; MEDTRONIC
`PUERTO RICO OPERATIONS CO.; and
`OSTEOTECH, INC.,
`
`Plaintiffs,
`
`vs.
`
`NUVASIVE, INC.,
`
`Defendant.
`
`AND RELATED COUNTERCLAIMS
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`JOINT DISCOVERY PLAN
`
`
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.814 Page 2 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Plaintiffs Warsaw Orthopedic, Inc.; Medtronic Sofamor Danek U.S.A., Inc.; Medtronic
`
`Puerto Rico Operations Co.; and Osteotech, Inc. (collectively “Plaintiffs”) and defendant NuVasive,
`
`Inc. (“NuVasive”) hereby jointly submit the following discovery plan for the above-captioned matter
`
`pursuant to Fed. R. Civ. P. 26(f), Patent Local Rule 2.1, and Chamber Rule IV.B. As required by
`
`Rule 26(f)(1), the parties have met and conferred in an effort to reach agreement on this report. A
`
`short explanatory statement from each party is included on matters where the parties differ.
`
`Proposed Discovery Schedule
`
`A.
`
`
`EVENT
`Fact Discovery Opens
`
`PLAINTIFFS’ PROPOSAL
`2/1/13 (Fed. R. Civ. P. 26(d))
`
`Parties to serve initial
`disclosures
`Parties to serve Disclosure of
`Asserted Claims and
`Preliminary Infringement
`Contentions (Patent L.R. 3.1)
`Parties to serve Preliminary
`Invalidity Contentions (Patent
`L.R. 3.3)
`Parties to exchange Preliminary
`Claim Construction and
`Extrinsic Evidence (Patent L.R.
`4.1)
`Parties to exchange Responsive
`Claim Constructions (Patent
`L.R. 4.1)
`Parties to file Joint Claim
`Construction Chart, Joint Claim
`Construction Worksheet, and
`Joint Hearing Statement (Patent
`L.R. 4.2)
`Last day to request leave to
`amend/supplement pleadings
`Claim construction discovery
`cutoff (Patent L.R. 4.3)
`Opening claim construction
`briefs due (Patent L.R. 4.4.a)
`
`2/14/13
`
`3/7/13
`
`5/6/13
`
`5/20/13
`
`6/3/13
`
`6/17/13
`
`7/1/13
`
`7/15/13
`
`7/29/13
`
`NUVASIVE’S PROPOSAL
`12/16/13 (or 7 days after claim
`construction hearing)
`2/14/13
`
`6/7/13
`
`8/6/13
`
`8/20/13
`
`9/3/13
`
`9/17/13
`
`8/22/14
`
`10/15/13
`
`10/29/13
`
`JOINT DISCOVERY PLAN
`
`1
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.815 Page 3 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`8/12/13
`
`11/12/13
`
`8/30/13 (or per Court’s
`calendar) (Patent L.R. 2.1.a.2)
`30 days after claim construction
`order
`
`12/9/13 (Patent L.R. 4.5)
`
`30 days after claim construction
`order
`
`50 days after claim construction
`order
`
`50 days after claim construction
`order
`
`Responsive claim construction
`briefs due (Patent L.R. 4.4.b)
`Claim construction and tutorial
`hearing (Patent L.R. 2.1)
`Parties to serve final
`infringement contentions based
`on claim construction order
`(Patent L.R. 3.6.a)
`Parties to serve final invalidity
`contentions based on claim
`construction order (Patent L.R.
`3.6.b)
`Parties to exchange list of
`expert witnesses expected to be
`called at trial
`Parties to exchange list of
`rebuttal expert witnesses
`expected to be called at trial
`Fact discovery cut-off
`
`Initial expert reports (by party
`with burden of proof on each
`issue)
`Rebuttal expert reports
`
`Reply Expert Reports (for
`secondary considerations of
`non-obviousness)
`Expert discovery cut-off
`
`10/15/13
`
`10/29/13
`
`11/18/13
`
`12/16/13
`
`1/13/14
`
`1/27/14
`
`2/24/14
`
`8/1/14 (or 3 weeks before the
`close of fact discovery)
`
`8/15/14 (or 1 week before the
`close of fact discovery
`
`8/22/14 (8 months after
`NuVasive proposes that fact
`discovery opens)
`9/22/14 (or 30 days after
`NuVasive proposes that fact
`discovery closes)
`10/22/14 (or 30 days after
`opening expert reports)
`11/5/14 (or 14 days after
`rebuttal expert reports)
`
`12/26/14 (4 months after fact
`discovery closes)
`1/23/14 (or 30 days after expert
`discovery cut-off)
`4/6/15
`
`Dispositive motion cut-off
`
`3/10/14
`
`Pretrial conference
`
`No changes will be made in timing, form, or requirement for 26(a) disclosures.
`Plaintiffs’ Statement Concerning Their Proposed Schedule
`
`4/7/14
`
`On August 17, 2012, Plaintiffs filed this case in the Northern District of Indiana against
`
`Defendant, NuVasive, Inc., alleging infringement of three of Plaintiffs’ patents by NuVasive’s
`
`manufacture and sale of certain medical devices and procedures used in spinal surgery. (Dkts. 1 &
`
`17.) On November 8, 2012, the Northern District of Indiana granted NuVasive’s motion to transfer
`
`JOINT DISCOVERY PLAN
`
`2
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.816 Page 4 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`this case to the Southern District of California. (Dkt. 32.) With respect to the dates on which the
`
`parties differ, Plaintiffs have proposed a schedule to resolve efficiently its patent infringement claims
`
`that have been pending for nearly six months. (Dkts. 1 & 17.) Under Plaintiffs’ proposed schedule,
`
`the parties would complete fact discovery by November 18, 2013 and expert discovery by February
`
`24, 2014, and would participate in the pretrial conference on April 7, 2014. Plaintiffs’ proposed
`
`schedule would allow this case to be scheduled for trial within 24 months.
`
`In contrast, NuVasive has proposed a schedule that would be inefficient and is contrary to the
`
`Federal and Local Rules. See Fed. R. Civ. P. 26(d); Patent L.R. 2.5. Under NuVasive’s proposal,
`
`fact discovery would not even begin until after the claim construction hearing. There is no reason
`
`why fact discovery cannot be conducted concurrently with claim construction briefing, as is typically
`
`done in patent cases and has been done in another patent case between the parties before this Court
`
`(Warsaw Orthopedic, Inc. v. NuVasive, Inc., Case No. 3:08-cv-01512-CAB-MDD). Indeed, the
`
`Local Rules prohibit a party from objecting to discovery requests as premature in light of the
`
`timetable for claim construction provided by these rules except where the requests seek to elicit a
`
`party’s claim construction position, a comparison of the asserted claims against the accused products
`
`or prior art, or the identification of opinions of counsel relating to allegations of willful infringement.
`
`Patent L.R. 2.5.
`
`Furthermore, NuVasive has proposed a schedule that runs counter to the arguments it made
`
`to the Northern District of Indiana to support its transfer motion. There, NuVasive argued that trial
`
`in California would not be slower than trial in Indiana because “complex patent cases of more than
`
`two patents will be scheduled for trial within 24 months” in this district. (Dkt. 30 at 9, n. 5.) Now,
`
`however, NuVasive proposes a schedule with a trial date well beyond the two-year mark. NuVasive
`
`also proposes to extend the last day to request leave to amend or supplement the pleadings to
`
`August 22, 2014 (to coincide with its proposed close of fact discovery), presumably so that it may
`
`take discovery on an unpleaded inequitable conduct defense. Plaintiffs submit that their proposed
`
`deadline of July 1, 2013 to amend or supplement pleadings is nearly one year from the filing of the
`
`Complaint and gives sufficient time for NuVasive to conduct any necessary investigation or
`
`JOINT DISCOVERY PLAN
`
`3
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.817 Page 5 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`discovery before amendment. NuVasive’s proposal would also leave the parties with no time to take
`
`discovery on any claims or defenses raised in the amended or supplemented pleadings.
`
`NuVasive now asserts no fewer than four separate reasons why it believes this case, which
`
`has been pending for nearly seven months, should be further delayed: 1) the Federal Circuit has yet
`
`to rule on the appeal of the Phase I jury verdict between the parties; 2) delaying this case would
`
`supposedly promote settlement; 3) NuVasive needs more time in order to assert its own patents; and
`
`4) bifurcating damages and willfulness would allegedly permit the parties to focus their discovery
`
`efforts. Each of these reasons fails. First, with the exception of the pending ongoing royalty issue,
`
`this Court has already decided the issues relating to liability and damages for the Phase I patents.
`
`There is no reason to assume (as NuVasive does) that the Court decided these issues incorrectly. In
`
`any event, a Federal Circuit appeal will likely be concluded before the trial in this matter, under
`
`either party’s proposed schedule. Second, Plaintiffs disagree that delay would promote settlement
`
`and instead believe the opposite to be true. Third, NuVasive has had nearly seven months since this
`
`case was filed to consider asserting its own patents and has failed to identify even one that it intends
`
`to assert. Finally, bifurcation of damages and willfulness, as well as all discovery relevant to those
`
`issues, would be inefficient and burdensome given the overlap of those issues with other fact issues
`
`in this case. This would lead to duplicative fact and expert depositions, and trial testimony, and
`
`would not promote judicial economy. Accordingly, Plaintiffs propose that the Court adopt its
`
`proposed schedule as set forth above and in accordance with the Local Rules.
`
`NuVasive’s Statement Concerning Its Proposed Schedule
`
`The Court should stay these proceedings until the Federal Circuit has ruled on the appeal of
`
`related Case No. 08-CV-1512 (“Phase 1”). Guidance from the Federal Circuit will help define the
`
`contours of this litigation and may help the parties reach a global resolution eliminating the need for
`
`this suit altogether. In the event the Court chooses not to stay, NuVasive proposes a phased
`
`approach to litigating this case – an approach that provides the parties time to resolve their disputes
`
`informally before being compelled to engage in expensive litigation. If the parties are unable to
`
`resolve their disputes through ENE and/or mediation within 90 days, then NuVasive would assert its
`
`JOINT DISCOVERY PLAN
`
`4
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.818 Page 6 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`own set of patents and the parties would proceed through preliminary contentions and claim
`
`construction briefing in accord with the Patent Local Rules. Then, with the benefit of the Court’s
`
`claim construction complete, liability fact discovery would begin, allowing the parties to focus their
`
`discovery efforts. (For the reasons discussed below, NuVasive proposes bifurcating damages and
`
`willfulness to allow time for the Phase 1 appeal to be decided by the Federal Circuit.) Finally,
`
`toward the end of liability fact discovery, the parties would be permitted to amend their pleadings to
`
`assert any claims of inequitable conduct. This timing under NuVasive’s proposal is also appropriate
`
`given the number of patents and technologies that would be at issue.
`
`In contrast, Plaintiffs seek to be rewarded for engaging in forum shopping (Plaintiffs first
`
`brought suit on their three asserted patents in the Northern District of Indiana rather than abiding by
`
`the sequencing that has governed the litigation between the parties from the outset) with an
`
`unreasonably expedited pre-trial procedure, which would have this case going to trial less than 18
`months from the date the case was transferred to and effectively filed in this Court, and which makes
`
`no accommodation for NuVasive to assert its own patents. To date, nothing substantive has
`
`occurred in the case other than the grant of NuVasive’s motion to transfer to this Court on November
`
`8, 2012. Indeed, pursuant to Court order, NuVasive was not even required to respond to Plaintiffs’
`
`complaint until November 30, 2012. See D.I. 26. Plaintiffs’ proposal would force NuVasive to
`
`escalate the litigation by asserting its patents now rather than allowing for meaningful settlement
`
`discussions to occur. While Plaintiffs complain of delay under NuVasive’s proposal, any delay was
`
`of Plaintiffs’ own making as the case was transferred back to this Court from Indiana. Moreover,
`
`Plaintiffs suffer no prejudice from the orderly, phased resolution of this case given the Court’s prior
`
`ruling regarding the impropriety of injunctive relief.
`
`There are other efficiencies to NuVasive’s phased approach as well. Most importantly, the
`
`Federal Circuit has not considered Warsaw’s damages theories or critical liability issues in Phase 1
`
`which overlap significantly with the claims Plaintiffs seek to pursue in this case. If NuVasive’s
`
`position on damages or liability is vindicated on appeal, the complexion of this litigation will change
`
`substantially and, NuVasive believes, the chances of settlement will be greatly increased. Under
`
`JOINT DISCOVERY PLAN
`
`5
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.819 Page 7 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Plaintiffs’ rushed approach, the parties and the Court may not benefit from the Federal Circuit’s
`
`guidance before another trial is had on Plaintiffs flawed theories.
`
`Finally, with regard to the patents asserted by Plaintiffs here, one (the ‘430) is involved in
`
`inter partes reexamination proceedings before the Patent Office, which in its initial office action has
`
`rejected all claims on multiple grounds. Under the procedures argued for by Warsaw itself and
`
`ordered by the Court in Phase 1, proceedings on that patent should therefore be stayed pending
`
`reexam, regardless of the other considerations outlined above.
`
`B.
`
`Scope of Discovery
`1.
`Subjects of Discovery
`
`At this time, the parties anticipate conducting discovery on the following issues, but reserve
`
`the right to supplement this list as further information becomes available:
`• The design, development, testing, and manufacturing of the products alleged to
`infringe the patents-in-suit;
`• Marketing, sales, and financial material for the products alleged to infringe the
`patents-in-suit;
`• The design, development, testing, and manufacturing of the embodying and
`competing products for the patents-in-suit;
`• Marketing, sales, and financial material for the embodying and competing products of
`the patents-in-suit;
`• Conception and reduction to practice of the patents-in-suit;
`• Prosecution of the patents-in-suit, including relevant prior art;
`• Alleged infringement of the patents-in-suit;
`• Alleged invalidity of the patents-in-suit;
`• Alleged unenforceability of and inequitable conduct related to the patents-in-suit; and
`• Monetary and equitable relief relating to the alleged infringement of the patents-in-
`suit.
`
`Additionally, due to the technical complexity of the case, the parties will need to conduct
`
`JOINT DISCOVERY PLAN
`
`6
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.820 Page 8 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`discovery relevant to expert opinions regarding infringement, invalidity, unenforceability, and
`
`damages. Daubert motions may be filed for each of these issues.
`
`Plaintiffs do not believe that discovery of any of the foregoing topics should be phased or
`
`otherwise limited except as described herein. NuVasive believes that damages and willfulness, as
`
`well as all discovery relevant to those issues, should be bifurcated until after a determination of
`
`liability. See Gen. Order 625, Amended Pat. L. R. 2.1(b)(3).
`2.
`
`Changes to Limitations on Discovery
`
`Plaintiffs propose that each party may take up to 100 hours of fact depositions, including any
`
`Rule 30(b)(6) depositions.
`
`NuVasive proposes that each party may take up to 125 hours of fact depositions, including
`
`any Rule 30(b)(6) depositions.
`
`The parties agree that discovery of expert materials be limited to final expert reports and
`
`materials relied upon in connection with those reports, and that communications with counsel and
`
`draft reports not be discoverable.
`
`Plaintiffs propose that all other discovery will be subject to the limits prescribed by this
`
`Court, the Local Rules, and the Federal Rules of Civil Procedure.
`
`NuVasive proposes that each side be allowed to serve up to 35 interrogatories, and that each
`
`side be allowed to propound up to 50 requests for admissions given the complexity of the case and
`
`that NuVasive will assert its own patents if the parties are unable to resolve this dispute. Otherwise,
`
`NuVasive proposes that other discovery be subject to the limits prescribed by this Court, the Local
`
`Rules, and the Federal Rules of Civil Procedure.
`3.
`
`Discovery of Electronically Stored Information
`
`The parties have agreed that electronically stored information (“ESI”) may be collected by
`
`performing reviews of reasonably accessible data sources. Reasonably accessible sources of ESI
`
`include active e-mail accounts, data associated with e-mail accounts that are no longer active but are
`
`reasonably accessible (for custodians identified who are no longer employed or associated with the
`
`party), e-mail stored in an email vault system, shared network drives and other live servers,
`
`JOINT DISCOVERY PLAN
`
`7
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.821 Page 9 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`workstation or laptop hard drives, external hard drives, and media such as CDs or DVDs. Neither
`
`party will retrieve data from the following sources (which are not reasonably accessible):
`
`Blackberries, iPhones, or PDAs; Instant Messages (IM); voicemails; backup tapes and systems
`
`created for the sole purpose of disaster recovery that are substantially duplicative of data that is more
`
`accessible elsewhere; residual, deleted, fragmented, damaged, or temporary data (e.g., data stored in
`
`a computer’s RAM); or encrypted data/password protected files, where the key or password cannot
`
`be ascertained after reasonable efforts. It is Plaintiffs’ position that backup tapes and systems
`
`created for the purpose of disaster recovery are not readily accessible, and therefore neither party
`
`shall retrieve data from these sources. NuVasive disagrees. Neither party contemplates taking
`
`forensic images of hard drives or decommissioned computer hardware at the present time. The
`
`parties further agree that neither party need deviate from the practices it normally exercises with
`
`regard to preservation of backup tapes and systems created for back-up or disaster recovery purposes
`
`(i.e., recycling of back-up tapes is permitted).
`
`The parties will conduct reviews and produce documents, subject to any applicable
`
`objections, based on the scope of the parties’ respective document requests. The parties will meet
`
`and confer regarding limiting electronic searches to a specific number of custodians and search
`
`terms. Each party reserves the right to seek further limits if the initial search results in excessive
`
`volume or cost, and if no agreement can be reached, to seek a protective order from the Court.
`
`The parties have agreed to meet and confer regarding production of information relating to
`
`products (e.g., product specifications, design history files kept for regulatory purposes, product
`
`descriptions, patient education information, product samples, product drawings, bills of materials)
`
`and patents (e.g., prosecution history files, prior art). The parties will attempt to agree on the scope
`
`of production of such documents without regard to specific custodians.
`
`With respect to productions, each party will initially produce all ESI in image format. Each
`
`individual document based on an electronic file shall be accompanied by a corresponding text file
`
`containing the searchable text for that document. The OCR text files should be created on a
`
`document level and be named to correspond to the first page Bates number of the corresponding
`
`JOINT DISCOVERY PLAN
`
`8
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.822 Page 10 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`document being produced (e.g. ABC000001.txt). Each production set of ESI shall be accompanied
`
`by a load file in a format conducive to the requesting party’s litigation support application database.
`
`The load file shall unitize the production images into their logical units and capture select document
`
`information, to the extent appropriate, including:
`(1)
`
`Field information: production begin number, production end number,
`
`production begin attachment, production end attachment, custodian, and page
`
`count.
`(2) With respect to email, metadata information including: to, from, cc/bcc, sent
`
`date, time sent, received date, received time, email subject, parent ID, and
`
`attachment ID.
`(3) With respect to electronic documents: the original file name, author, date
`
`created, date last modified, time created, and time last modified.
`
`The parent-child relationships between documents and their attachments shall be maintained.
`
`If the ESI is in a format that cannot be readily converted to an image format, such as spreadsheets
`
`(XLS, CVS, etc…), the file will be produced in its native format as well, except for redacted files.
`
`The parties reserve the right to request native format versions of other ESI during discovery where
`
`there is a need to sort, filter or organize the information associated with the ESI. Due to the nature
`
`or complexity of storage of some ESI (e.g., ESI in proprietary applications), conversion to image and
`
`searchable text may be overly burdensome. The parties reserve the right to provide this ESI in a
`
`reasonable format.
`
`Certain types of files such as system, program, and legacy files are not amenable to
`
`conversion into TIFF format. In general, these types of files will not be collected; however, when
`
`they are present in the collection the files will not be converted into TIFF format but will be
`
`represented in the form of a placeholder TIFF image. These files may be produced in a reasonably
`
`usable form upon a showing of the need for and relevance of the file. Other files may not be able to
`
`be converted to TIFF image due to password protection, encryption or corruption (for example). If
`
`reasonable efforts to obtain useful TIFF images of these files are unsuccessful, these files will be
`
`JOINT DISCOVERY PLAN
`
`9
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.823 Page 11 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`represented in the form of a placeholder TIFF image, and the parties may discuss an alternative form
`
`of production upon a showing of the need for and relevance of the file.
`
`Paper documents will be produced as black-and-white single-page OCR’d TIFFs, with
`
`accompanying litigation support files.
`
`Plaintiffs propose that documents previously produced by the parties in Case No. 3:08-cv-
`
`01512-CAB that are responsive to requests propounded in this case shall be reproduced in the same
`
`form as previously produced. NuVasive proposes that documents previously produced by the parties
`
`in Case No. 3:08-cv-01512-CAB that are responsive to requests propounded in this case shall be
`
`reproduced and shall be in a form compliant with the above requirements.
`
`If a party inadvertently discloses information subject to the attorney-client privilege, work
`
`product immunity, a legal prohibition against disclosure, or other privilege or immunity, such
`
`disclosure shall not constitute a waiver of the applicable privilege or legal prohibition against
`
`disclosure if, after becoming aware of the inadvertent disclosure, the producing party provides
`
`prompt notice of the claimed inadvertent disclosure to each receiving party. After being notified, a
`
`party must promptly return or destroy the specified information and any copies it has; must not use
`
`or disclose the information until the claim is resolved; and must take reasonable steps to retrieve the
`
`information if the party disclosed it before being notified. To the extent the claimed inadvertent
`
`disclosure is subject to challenge, the receiving party may retain a single copy of the document for
`
`presentation to the Court under seal within ten days of discovering the inadvertent disclosure for a
`
`determination of the claim. The producing party must preserve the information until the claim is
`
`resolved and must not use the information for any other purpose until the Court rules on the claim,
`
`and following the ruling only to the extent the allowed in the Court’s ruling. Inadvertent production
`
`will be further addressed in the protective order.
`
`The parties agree that all documents shall be produced in a legible form where the original is
`
`in legible form. NuVasive proposes that documents produced in prior litigations shall be reproduced
`
`from the original documents. Color documents shall be produced as color images where grey scale
`
`images result in the document becoming illegible (e.g., document output through Relativity) and in
`
`JOINT DISCOVERY PLAN
`
`10
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.824 Page 12 of 14
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`any event at the reasonable request of the receiving party.
`
`The parties reserve the right to seek shifting or sharing of certain discovery costs, including
`
`vendor and attorney fees, in appropriate circumstances.
`4.
`
`Privilege and Protective Order Issues
`
`Discovery in this case will likely require production of confidential and/or proprietary
`
`information. The parties intend to work together to stipulate to a protective order to be filed in due
`
`course, including a stipulation regarding preserving the right to assert privilege on inadvertently
`
`produced documents. With respect to documents withheld on the basis of privilege, the parties will
`
`identify any such documents on privilege logs to be exchanged at a mutually agreeable time. The
`
`parties agree that privileged documents generated after the filing of this lawsuit need not be logged.
`5.
`
`Discovery Enabling the Parties to Make a Reasonable Settlement
`
`Evaluation
`
`Plaintiffs believe that preliminary infringement and invalidity contentions as provided in the
`
`claim construction procedure may help the parties in the settlement process. NuVasive disagrees.
`
`C.
`Claim Construction
`The parties do not anticipate presenting live testimony at the claim construction hearing.
`
`Additional limits on discovery related to claim construction are not needed, except to the extent
`
`discussed herein or prescribed by the Patent Local Rules.
`
`D.
`Other Orders or Issues
`The parties are not aware of any other issues at this time.
`
`DATED: February 14, 2013
`
`Respectfully submitted,
`
`
`
` /s/ Nimalka R. Wickramasekera
`Nimalka R. Wickramasekera
`KIRKLAND & ELLIS LLP
`
`Attorneys for Plaintiffs/Counterclaim Defendants
`WARSAW ORTHOPEDIC, INC.; MEDTRONIC
`SOFAMOR DANEK USA, INC.; MEDTRONIC
`PUERTO RICO OPERATIONS CO.; AND
`OSTEOTECH, INC.
`
`
`JOINT DISCOVERY PLAN
`
`11
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.825 Page 13 of 14
`
`DATED: February 14, 2013
`
`Respectfully submitted,
`
` /s/ Michael A. Amon
`Michael A. Amon
`FISH & RICHARDSON P.C.
`
`Attorneys for Defendant and Counterclaimant
`NUVASIVE, INC.
`
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`JOINT DISCOVERY PLAN
`
`12
`
`CASE NO: 3:12-CV-02738
`
`
`
`Case 3:12-cv-02738-CAB-MDD Document 49 Filed 02/14/13 PageID.826 Page 14 of 14
`
`CERTIFICATE OF SERVICE
`I am employed in the County of Los Angeles; I am over the age of eighteen years and not a
`
`party to the within entitled action; my business address is 333 South Hope Street, Los Angeles,
`
`California 90071.
`
`On February 14, 2013, true and correct copies of the foregoing document were served to all
`
`counsel of record who are deemed to have consented to electronic service via the Court’s CM/ECF
`
`system per Civil Local Rule 5.4. Any other counsel of record will be served by electronic mail,
`
`facsimile, U.S. Mail and/or overnight delivery.
`
`
`
`FEDERAL: I declare under penalty of perjury under the laws of the United States of
`
`America that the foregoing is true and correct.
`
`Executed on February 14, 2013, in Los Angeles, California.
`
` /s/ Nimalka R. Wickramasekera
` Nimalka R. Wickramasekera
`
`1
`
`2
`
`3
`
`4
`
`53
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`CERTIFICATE OF SERVICE
`
`
`
`CASE NO: 3:12-CV-02738
`
`